LPL Financial
ENTA icon

LPL Financial’s Enanta Pharmaceuticals ENTA Stock Holding History

LPL Financial’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25,425
Closed -$673K – 2706
2016
Q3 		$673K Buy
+25,425
New +$591K 0.01% 1485
2016
Q2 		– Sell
-59,030
Closed -$1.74M – 2715
2016
Q1 		$1.74M Buy
59,030
+21,648
+58% +$603K ﹤0.01% 1291
2015
Q4 		$1.22M Buy
37,382
+17,739
+90% +$578K ﹤0.01% 1526
2015
Q3 		$766K Buy
19,643
+13,439
+217% +$577K ﹤0.01% 1446
2015
Q2 		$278K Buy
+6,204
New +$241K ﹤0.01% 2371

Other funds holding ENTA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LPL Financial's ENTA Position: Q4 2016 in Review

LPL Financial sold out of Enanta Pharmaceuticals (ENTA) in Q4 2016, closing a stake of 25,425 shares — an estimated $673K sold.

LPL Financial first reported a position in ENTA in Q2 2015 and held it in 5 quarters. The position peaked at $1.74M in Q1 2016. 149 funds tracked by Wall St. Rank hold ENTA as of Q4 2016.

  • LPL Financial reported no remaining Enanta Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • LPL Financial sold 25,425 Enanta Pharmaceuticals shares in Q4 2016, an estimated $673K.
  • LPL Financial first reported a position in Enanta Pharmaceuticals in Q2 2015 and held it in 5 quarters.
  • LPL Financial's Enanta Pharmaceuticals position peaked at $1.74M in Q1 2016.
  • 149 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2016.

Based on LPL Financial's 13F filing for Q4 2016, filed 13 Feb 2017.